Hyperfine announces two presentations at AAIC

Hyperfine announced that two presentations on the clinical utility of portable ultra-low-field MRI for Alzheimer’s disease monitoring have been accepted in the developing topics poster sessions at the upcoming 2024 Alzheimer’s Association International Conference, AAIC, July 28-August 1 in Philadelphia. “With the recent developments in Alzheimer’s therapies and care, the medical community has shown tremendous interest in incorporating portable ultra-low-field MR brain imaging into the continuum of care for Alzheimer’s patients, taking advantage of the system’s versatility to scan in diverse professional care settings. We are very excited to be attending the AAIC conference for the first time this year in Philadelphia,” said Maria Sainz, President and CEO of Hyperfine.